Morgan Stanley Call 11 DVAX 20.09.../ DE000MG0FYM1 /
24/06/2024 9:47:11 | Diferencia-0.02 | Bid10:04:25 | Ask10:04:25 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
1.08EUR | -1.82% | 1.08 Volumen de oferta: 3,750 |
- Tamaño/ Volumen/ Formato de Ask: - |
Dynavax Technologies... | 11.00 USD | 20/09/2024 | Call |
GlobeNewswire
10:00
OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
9:53
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Cla...
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
7:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página